SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 8.21% growth in the revenue at Rs. 5551.40 millions for the quarter ended December 2021 as compared to Rs. 5130.10 millions during the year-ago period.Net profit of the cmpany stood at Rs. 400.70 millions for the quarter ended December 2021 a decline of -65.10% from Rs. 1148.10 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 680.90 millions from 1650.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 5551.40 5130.10 8.21 16115.30 15066.00 6.96 19669.80 18944.70 3.83
Other Income 88.80 78.10 13.70 251.10 180.90 38.81 243.00 160.20 51.69
PBIDT 680.90 1650.60 -58.75 2382.70 4987.60 -52.23 6161.40 5899.00 4.45
Interest 22.90 14.60 56.85 59.50 43.90 35.54 58.30 209.30 -72.15
PBDT 658.00 1636.00 -59.78 2183.90 4943.70 -55.82 6103.10 5689.70 7.27
Depreciation 111.30 99.70 11.63 322.50 289.50 11.40 389.20 357.30 8.93
PBT 546.70 1536.30 -64.41 1861.40 4654.20 -60.01 5713.90 5332.40 7.15
TAX 146.00 388.20 -62.39 482.30 961.10 -49.82 1268.30 1719.50 -26.24
Deferred Tax 2.50 1.10 127.27 -0.40 -217.90 -99.82 -187.20 10.50 -1882.86
PAT 400.70 1148.10 -65.10 1379.10 3693.10 -62.66 4445.60 3612.90 23.05
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 568.90 3.20
PBIDTM(%) 12.27 32.17 -61.88 14.79 33.11 -55.34 31.32 31.14 0.60

IOL Chem & Pharma Share Price

96.50 1.84 (1.94%)
06-May-2026 11:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1840.90
Dr. Reddys Lab 1284.30
Cipla 1356.30
Zydus Lifesciences 929.65
Lupin 2408.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×